Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores

Scientia Pharmaceutica

Volumn 77, Issue 3, 2009, Pages 625-637

  Bora, Pushpak S ^a   Puri, Vibha ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Drug Excipient interaction; Lactic acid bacteria; Preformulation; Probiotic

Indexed keywords

CITRIC ACID; MEGLUMINE; PROBIOTIC AGENT; STARCH GLYCOLATE SODIUM;

AQUEOUS SOLUTION; ARTICLE; BACILLUS COAGULANS; BACTERIAL SPORE; DRUG DEGRADATION; DRUG STABILITY; EXCIPIENT COMPATIBILITY; MICROBIOLOGY; MOISTURE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PREFORMULATION; WETTABILITY;

EID: 70349278676     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0904-01     Document Type: Article

References (28)

1. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989; 66: 365-378. doi:10.1111/j.1365-2672.1989.tb05105.x
2. Anal AK, Singh H. Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends Food Sci Technol. 2007; 18: 240-251. doi:10.1016/j.tifs.2007.01.004 (Pubitemid 46667227)
3. Bongaerts GP, Severijnen RS. The beneficial, antimicrobial effect of probiotics. Med Hypotheses. 2001; 56: 174-177. doi:10.1054/mehy.2000.1135
4. Camilleri M. Irritable bowel syndrome: newer pharmacological agents acting on the gut. Int Congr Ser. 2002; 1241: 143-148. doi:10.1016/S0531- 5131(02)00630-1
5. Sanders ME, Morelli L, Tompkins TA. Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Compr Rev Food Sci Food Sav. 2003; 2: 101-110. doi:10.1111/j.1541-4337.2003.tb00017.x
6. Hong HA, Duc LH, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbio Rev. 2005; 29: 813-835. doi:10.1016/j.femsre.2004.12. 001
7. Nighswogner BD, Brashears MM, Gilliand SE. Viability of Lactobacillus acidophillus and lactobacillus casei in fermented milk products during refrigerated storage. J Dairy Sci. 1996; 79: 212-219. PMid:8708082
8. Maggi L, Mastromarino P, Macchia S, Brigidi P, Pirovano F, Matteuzzi D, Conte U. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur J Pharm Biopharm. 2000; 50: 389-395. doi:10.1016/S0939-6411(00)00121-1 (Pubitemid 30799174)
9. Juarez Tomas MS, Ocana VS, Nader-Macias ME. Viability of vaginal probiotic lactobacilli during refrigerated and frozen storage. Anaerobe. 2004; 10: 1-5. doi:10.1016/j.anaerobe.2004.01.002
10. Storz G, Hengre-Aronis R, editors. Resistance of bacterial spores. In: Bacterial stress responces. Washington DC: ASM Press, 2000: 217-238.
11. Jin P. Method and composition for producing stable bacteria and bacterial composition. US patent 5733774. 1998.
12. Callahan JC, Cleary GW, Elefant M, Kaplan G, Kensler T, Nash RA. Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm. 1982; 8: 355-369. doi:10.3109/03639048209022105
13. Beuchat LR. Influence of water activity on growth, metabolic activities, and survival of yeasts and molds. J Food Protection. 1983; 46: 135-141.
14. Porubcan RS. Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life. US patent 7122370. 2006.
15. Fazeli MR, Toliyat T, Samadi N, Hajjaran S, Jamalifar H. Viability of lactobacillus acidophillus in various vaginal tablet formulations. Daru. 2006; 14: 172-177. (Pubitemid 46219384)
16. Durand H, Panes J. Particles containing coated living microorganisms, and method for producing same. US patent 7157258. 2007.
17. Sean F. Probiotics, lactic acid-producing bacteria and uses thereof. US patent 6461607. 2002.
18. Zárate G, Juárez Tomás MS, Nader-Macias ME. Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli. Can J Microbiol. 2005; 51: 483-489. doi:10.1139/w05-031
19. Carvalho AS, Silva J, Ho P, Teixera P, Malcata FX, Gibbs P. Survival of freeze dried lactobacillus plantarum and lactobacillus rhamnosus during storage in the presence of protectants. Biotechnol Lett. 2002; 24: 1587-1591. doi:10.1023/A:1020301614728
20. Serajuddin AT, Thakur AB, Ghoshal RN, Fakes MG, Ranadive SA, Morris KR, Varia SA. Selection of solid dosage form composition through drug-excipient compatibility testing. J Pharm Sci. 1999; 88: 696-704. doi:10.1021/js980434g
21. Kibbe AH, editors. Colloidal silicon dioxide. In: Handbook of Pharmaceutical Excipients. 3rd ed. London: Pharmaceutical Press, 2000: 143-145.
22. Gianella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972; 13: 251-256. doi:10.1136/gut.13.4.251
23. Hyronimus B, Le Marrec C, Sassi AH, Deschamps A. Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol. 2000; 61: 193-197. doi:10.1016/S0168-1605(00)00366-4 (Pubitemid 30764874)
24. Kim S-J, Cho SY, Kim SH, Song O-J, Shin IIS, Cha DS, Park HJ. Effect of microencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT Food Sci Technol. 2008; 41: 493-500. doi:10.1016/j.lwt.2007.03.025
25. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001; 46: 75-87. doi:10.1016/S0169-409X(00)00130-7 (Pubitemid 33653415)
26. Favaro-Trindade CS, Grosso CR. Microencapsulation of L. acidophilus (La-05) and B. lactis (Bb-12) and evaluation of their survival at the pH values of the stomach and in bile. J Microencapsul. 2002; 19: 485-494. doi:10.1080/02652040210140715
27. Brown IE, McNaught KJ, Ganly R, Conway P, Evans AJ, Topping D, Wang X. Probiotic compositions. US patent 6060050. 2000.
28. Crittenden R, Weerakkody R, Sanguansri L, Augustin M. Synbiotic microcapsules that enhance microbial viability during nonrefrigerated storage and gasstrointestinal transit. Appl Environ Microbiol. 2006; 72: 2280-2282. doi:10.1128/AEM.72.3.2280-2282.2006